Notably, in the case of gastrointestinal tract oncogenesis, the TROP-2 protein has been shown to be expressed at high levels in colon and gastric cancer and in hilar cholangiocarcinoma [4]. This evidence concerns the gene TACSTD2 and gastric cancer.